Epizyme Inc. (NASDAQ: EPZM) started the day on September 14, 2020, with a price increase of 8.50% at $13.02. During the day, the stock rose to $13.48 and sunk to $12.23 before settling in for the price of $12.00 at the close. Taking a more long-term approach, EPZM posted a 52-week range of $9.73-$27.82.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -10.50%. Meanwhile, its Annual Earning per share during the time was -3.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -12.00%. This publicly-traded company’s shares outstanding now amounts to $101.10 million, simultaneously with a float of $82.79 million. The organization now has a market capitalization sitting at $1.34 billion. At the time of writing, stock’s 50-day Moving Average stood at $13.53, while the 200-day Moving Average is $17.87.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 203 employees. It has generated 117,241 per worker during the last fiscal year. Meanwhile, its income per employee was -838,892. The stock had 1.96 Receivables turnover and 0.07 Total Asset turnover. For the Profitability, stocks operating margin was -744.29 and Pretax Margin of -715.28.
Epizyme Inc. (EPZM) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Epizyme Inc.’s current insider ownership accounts for 0.60%, in contrast to 96.90% institutional ownership. According to the most recent insider trade that took place on Sep 02, this organization’s Corporate Controller sold 543 shares at the rate of 12.88, making the entire transaction reach 6,994 in total value, affecting insider ownership by 5,958. Preceding that transaction, on Jun 26, Company’s Director bought 62,019 for 16.03, making the whole transaction’s value amount to 994,165. This particular insider is now the holder of 82,601 in total.
Epizyme Inc. (EPZM) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 6/29/2020, the organization reported -$0.58 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.61) by $0.03. This company achieved a net margin of -715.53 while generating a return on equity of -60.37. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.65 per share during the current fiscal year.
Epizyme Inc.’s EPS decrease for this current 12-month fiscal period is -12.00% and is forecasted to reach -2.12 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 38.00% through the next 5 years, which can be compared against the -3.00% growth it accomplished over the previous five years trading on the market.
Epizyme Inc. (NASDAQ: EPZM) Trading Performance Indicators
Let’s observe the current performance indicators for Epizyme Inc. (EPZM). It’s Quick Ratio in the last reported quarter now stands at 11.20. The Stock has managed to achieve an average true range (ATR) of 0.68. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 96.86.
In the same vein, EPZM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.08, a figure that is expected to reach -0.60 in the next quarter, and analysts are predicting that it will be -2.12 at the market close of one year from today.
Technical Analysis of Epizyme Inc. (EPZM)
If we take a close look at the recent performances of Epizyme Inc. (NASDAQ: EPZM), its last 5-days Average volume was 0.86 million that shows plunge from its year to date volume of 1.07 million. During the previous 9 days, stock’s Stochastic %D was recorded 30.90% While, its Average True Range was 0.75.
Raw Stochastic average of Epizyme Inc. (EPZM) in the period of the previous 100 days is set at 11.87%, which indicates a major fall in contrast to 72.46% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 53.17% that was lower than 58.47% volatility it exhibited in the past 100-days period.